Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163385 | SCV000213925 | likely benign | Hereditary cancer-predisposing syndrome | 2016-06-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000560674 | SCV000639297 | likely benign | Familial adenomatous polyposis 2 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000607333 | SCV000728309 | likely benign | not specified | 2018-03-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000163385 | SCV000905848 | likely benign | Hereditary cancer-predisposing syndrome | 2018-05-15 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000560674 | SCV001135246 | likely benign | Familial adenomatous polyposis 2 | 2019-05-28 | criteria provided, single submitter | clinical testing |